Search - tctmd.com

December 23, 2025

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

August 29, 2025

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

April 02, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

February 02, 2024

News Daily News

FDA Approves Portico TAVI Valve, Paving the Way for Third US Device

Shelley Wood

September 20, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

April 01, 2021

News Daily News

FDA Approves Harmony TPV for Pulmonary-Valve Regurgitation in Congenital HD

March 26, 2021

News Daily News

European Regulators Approve First Transcatheter MV Replacement Device

January 30, 2020

News Conference News STS 2020

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

January 29, 2020

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

November 06, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

August 16, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Industry News

Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System

April 23, 2019

News Daily News

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

January 14, 2019

News Daily News

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

Caitlin E. Cox

September 05, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

August 17, 2018

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

July 10, 2017

News Daily News

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

June 06, 2017

News Daily News

FDA Approves 34-mm TAVR Valve for Patients With Larger Anatomy

October 27, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe